Literature DB >> 2592118

Breast milk antibodies to foods in relation to maternal diet, maternal atopy and the development of atopic disease in the baby.

K Fälth-Magnusson1.   

Abstract

Breast milk samples were collected from 152 women during the first week after delivery. The levels of IgG and IgA antibodies to beta-lactoglobulin, ovalbumin and gliadin were assessed with an enzyme-linked immunosorbent assay (ELISA). The breast milk antibody levels did not differ significantly between mothers on a strictly cow's milk and egg-free diet, and mothers taking these foods. Moreover, the colostral food antibody levels did not differ significantly between atopic and non-atopic mothers. Neither was there any correlation between the colostral antibody levels and the development of atopic disease in the baby. I conclude that maternal antigen avoidance during late pregnancy does not affect the food antibody levels in colostrum. High levels of food antibodies in a colostrum sample seem not to offer protection against food allergy in the child.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592118     DOI: 10.1159/000235041

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  Anti-gliadin antibodies in breast milk from celiac mothers on a gluten-free diet.

Authors:  María Roca; Sabine Lisa Vriezinga; Paula Crespo-Escobar; Renata Auricchio; David Hervás; Gemma Castillejo; Maria Carmen Mena; Isabel Polanco; Riccardo Troncone; Maria Luisa Mearin; Carmen Ribes-Koninckx
Journal:  Eur J Nutr       Date:  2017-05-29       Impact factor: 5.614

2.  IgA antibodies in human milk: epidemiological markers of previous infections?

Authors:  K A Nathavitharana; D Catty; A S McNeish
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

3.  Role of maternal elimination diets and human milk IgA in the development of cow's milk allergy in the infants.

Authors:  K M Järvinen; J E Westfall; M S Seppo; A K James; A J Tsuang; P J Feustel; H A Sampson; C Berin
Journal:  Clin Exp Allergy       Date:  2014-01       Impact factor: 5.018

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.